Diagnosis and Management of Graves’ Disease in Thailand: A Survey of Current Practice

Figure 1

Percentage of participants who would obtain the listed laboratory test (a) or functional and anatomic study (b) in a patient with uncomplicated Graves’ disease. International differences in the selection of laboratory tests or imaging studies are also shown. USA and EU data are from references 5 and 6, respectively. CBC, complete blood count; EU, Europe; LFT, liver function test; T3, triiodothyronine; T4, thyroxine; Tg Ab, thyroglobulin antibody; TPO Ab, thyroperoxidase antibody; TRAb, TSH receptor antibody; USA, United States of America.

(a)

(b)